Exosome-based Biotherapeutics: Opportunities, development and path to commercialization by Konstantinov, Konstantin
EXOSOME-BASED BIOTHERAPEUTICS:  OPPORTUNITIES, DEVELOPMENT AND PATH TO 
COMMERCIALIZATION  
 
 Konstantin Konstantinov, Codiak BioSciences, USA 
 
 
Over the last quarter century, we have witnessed the emergence of a diverse portfolio of biotech drug 
modalities, ranging from recombinant proteins to cell and tissue therapies.  In general, there is a trend toward 
growing drug complexity, following the deeper understanding of disease biology.  While the biochemical 
engineering concepts employed in the manufacturing of these modalities reflect this diversity, significant benefits 
have been gained through development of bioprocessing platforms with broader applicability.  This presentation 
will focus on the potential of exosome-based therapeutics, a new modality that has witnessed tremendous 
progress over the last few years.  The bioprocess and analytical technologies for their future commercialization 
will be discussed in the context of the capabilities and limitations of the existing biomanufacturing platforms. 
 
 
